Amsurg Corp. (AMSG) Shares Sold by Essex Investment Management Co. LLC
Essex Investment Management Co. LLC lowered its position in Amsurg Corp. (NASDAQ:AMSG) by 1.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 5,740 shares of the company’s stock after selling 102 shares during the period. Essex Investment Management Co. LLC’s holdings in Amsurg Corp. were worth $445,000 as of its most recent filing with the SEC.
Several other hedge funds have also recently added to or reduced their stakes in the company. State Street Corp increased its stake in Amsurg Corp. by 3.9% in the first quarter. State Street Corp now owns 1,821,003 shares of the company’s stock worth $135,849,000 after buying an additional 68,181 shares during the last quarter. Pegasus Partners Ltd. purchased a new stake in Amsurg Corp. during the first quarter worth approximately $626,000. Credit Agricole S A increased its stake in Amsurg Corp. by 105.4% in the first quarter. Credit Agricole S A now owns 174,109 shares of the company’s stock worth $12,989,000 after buying an additional 89,359 shares during the last quarter. Huntington Asset Advisors Inc. purchased a new stake in Amsurg Corp. during the first quarter worth approximately $597,000. Finally, M&T Bank Corp increased its stake in Amsurg Corp. by 39.8% in the first quarter. M&T Bank Corp now owns 5,538 shares of the company’s stock worth $413,000 after buying an additional 1,576 shares during the last quarter. Institutional investors and hedge funds own 98.42% of the company’s stock.
Amsurg Corp. (NASDAQ:AMSG) traded down 0.72% during trading on Friday, reaching $66.03. 994,485 shares of the company’s stock were exchanged. The company has a market capitalization of $3.55 billion, a PE ratio of 19.59 and a beta of 0.68. The company’s 50-day moving average is $65.63 and its 200-day moving average is $73.31. Amsurg Corp. has a 1-year low of $58.37 and a 1-year high of $87.29.
Amsurg Corp. (NASDAQ:AMSG) last posted its quarterly earnings data on Tuesday, August 2nd. The company reported $1.10 EPS for the quarter, topping analysts’ consensus estimates of $1.08 by $0.02. Amsurg Corp. had a net margin of 6.53% and a return on equity of 8.20%. The firm earned $758.50 million during the quarter, compared to analyst estimates of $769.88 million. During the same quarter last year, the business posted $0.97 EPS. The company’s revenue was up 21.5% on a year-over-year basis. Equities research analysts expect that Amsurg Corp. will post $4.33 earnings per share for the current fiscal year.
A number of research firms have recently commented on AMSG. Mizuho upped their price objective on Amsurg Corp. from $90.00 to $95.00 and gave the stock a “buy” rating in a report on Friday, June 24th. Cantor Fitzgerald restated a “buy” rating and set a $95.00 price objective on shares of Amsurg Corp. in a report on Thursday, July 14th. Robert W. Baird restated a “buy” rating on shares of Amsurg Corp. in a report on Thursday, June 16th. Goldman Sachs Group Inc. reiterated a “buy” rating on shares of Amsurg Corp. in a report on Friday, June 17th. Finally, Zacks Investment Research upgraded Amsurg Corp. from a “hold” rating to a “buy” rating and set a $88.00 price target for the company in a report on Monday, July 11th. Three analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Amsurg Corp. presently has a consensus rating of “Buy” and a consensus price target of $92.09.
In related news, insider Robert Jon Coward sold 7,500 shares of the firm’s stock in a transaction that occurred on Friday, August 26th. The shares were sold at an average price of $63.65, for a total value of $477,375.00. Following the completion of the transaction, the insider now owns 97,507 shares of the company’s stock, valued at approximately $6,206,320.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 2.30% of the stock is currently owned by corporate insiders.
Amsurg Corp. Company Profile
AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.
Want to see what other hedge funds are holding AMSG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amsurg Corp. (NASDAQ:AMSG).
Receive News & Ratings for Amsurg Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amsurg Corp. and related companies with MarketBeat.com's FREE daily email newsletter.